University of Washington School of Medicine Professor, Medical OncologyAppointed: 2009 University of Washington Seattle Cancer Care Alliance Medicine Director, Breast Medical OncologyAppointed: 2007 Fred Hutchinson Cancer Research Center Clinical Research Division Breast Associate MemberAppointed: 2006 Fred Hutchinson Cancer Research Center Breast Cancer Program Associate Program HeadAppointed: 2001 |  |
QualificationsM.D., University Southern California, 1988. B.S., Stanford University, 1981. Expertise and Research InterestsJulie Gralow majored in biologic sciences at Stanford University before attending medical school at the University of Southern California. She completed a residency in internal medicine at Harvard Medical School's Brigham and Women's Hospital, followed by a medical oncology fellowship at the University of Washington School of Medicine and the Fred Hutchinson Cancer Research Center, two institutions at which she currently holds joint faculty appointments.
Specializing in breast cancer, Dr. Gralow is the co-Chair of the Southwest Oncology Group's Breast Cancer Committee. She is the Principle Investigator on numerous local and national clinical trials related to breast cancer treatment, prevention, and survivorship. Her area of research specialization is the relationship between breast cancer and the bone, and she currently leads a 4,500 patient Phase III North American Breast Intergroup group trial investigating the role of bisphosphonates in preventing bone metastases.
Dr. Gralow is committed to improving quality of life for breast cancer patients through education, exercise and diet, and to promoting breast cancer awareness in the community. Dr. Gralow is the Medical Director and Team Physician for 'Team Survivor Northwest,' a group of female cancer survivors dedicated to improving their health through fitness and exercise.
She is board-certified in in medical oncology, and is a member of the American Society of Clinical Oncology, Southwest Oncology Group, American Association for Cancer Research, Puget Sound Oncology Consortium, the American Society of Breast Disease, and Washington State Medical Oncology Society.
Dr. Gralow is Co-Chair of the Breast Scientific Leadership Council of the Coalition of Cancer Cooperative Groups. She is an elected member of the American Society of Clinical Oncology's (ASCO) Nominating Committee, was Chair for ASCO's Cancer Communications Committee in 2008-09, and served as Co-Chair of an NCI State of the Science Conference on Preoperative Therapy in Breast Cancer in 2007. She has served as a Board Member of the American Society of Breast Disease, and directs the American Cancer Society/UW Medical Student Summer Research Fellowship Program. Other ExpertiseVice-Chair, Southwest Oncology Group (SWOG) Breast Cancer Committee 2000-present
Executive Committee Member, SWOG Committee on Special Populations/Survivorship 1995-present
Co-Chair, Breast Scientific Leadership Council Steering Committee, Coalition of Cancer Cooperative Groups 2005-present
American Society of Clinical Oncology Member, ASCO Nominating Committee 2008-present Member, ASCO Cancer Communications Committee 2005-present, Chair 2007/2008 Chair, ASCO Patient Communication Subcommittee 2005-2007 Member, ASCO Public Issues Committee 1999-2004; Co-Chair, 2000-2002 Member, ASCO Program Committee 2000 Member/Liaison, ASCO Health Services Research Committee 2000-2004
Member, Breast Health Advisory Panel, National Women's Health Resource Center 2005-present
Section Editor, Breast Cancer, UpToDate 2009-present Editorial Board, Breast Diseases 2005-present Editorial Board, The Breast Journal 2006-present Editorial Board, Clinical Cancer Advances 2006-present Editorial Advisor, Advances in Targeted Cancer Therapies, 2003-2007
Senator, University of Washington Faculty Senate 2002-2004
Fred Hutchinson Cancer Research Center Scientific Steering Committee 2002-present
Director, American Cancer Society/University of Washington Medical Student Summer Research Fellowship Program 1996-present
Member-at-Large, University of Washington Medical Staff Advisory Committee, 1998-2006
Co-Director, University of Washington Medical Center (UWMC) Patient and Family Education Committee 1996-2003
Member, University of Washington School of Medicine (UWSOM) Human Subjects Review Committee 1998 - 2000
Executive Committee Member, Seattle Breast Cancer Research Program 1995-present
Member, Puget Sound Oncology Consortium Breast Committee, 1994-present
Delegate, University of Washington Center for Women and Democracy, Cuba Mission 2003; Baltic Mission 2003; South Africa Mission 2004, Ukraine Mission 2005, China Mission 2006 + 2008, Morocco 2009
Consultant, Program for Appropriate Technology in Health (PATH), USAID Ukraine Breast Cancer Assistance Project 1997-2000
Member, Expedition Inspiration Breast Cancer Foundation Medical Advisory Board, 1999-present; Chair, 2001-2007
Professional Advisory Committee Member, Living Beyond Breast Cancer, 2005-present
Professional Advisory Board Member, Breast Cancer.org, 2004-present
Board Member, Puget Sound Affiliate of the Susan G. Komen Breast Cancer Foundation 1996-2001
Advisory Board Member, Puget Sound Affiliate of the Susan G. Komen Breast Cancer Foundation 2004-present
Physician Advisor, Marsha Rivkin Ovarian Cancer Center 1995-present
Member, Cancer Lifeline Medical Advisory Committee 1996-present; Chair, 1996-1998
Team Physician and Medical Director, Team Survivor Northwest 1995-present KeywordsCOS Keywords:Breast Cancer, Cancer or Carcinogenesis, Health and Medicine, Oncogenes, Oncology, Tumors.Additional Terms:Bone Metastasis, Breast Cancer, Cancer, Oncogenes, Oncology, Tumor Biology.MembershipsAmerican Association for Cancer Research American Society of Breast Disease American Society of Clinical Oncology Puget Sound Oncology Consortium Southwest Oncology Group Washington State Medical Oncology Society Honors and Awards2008, Fellow,
American College of Physicians
2008, Statesman Award,
American Society of Clinical Oncology
2008, Service Excellence Award,
University of Washington Medical Center
2007, Certificate of Appreciation for Significant Contributions as Co-Chair of NCI's State of the Science Conference on Preoperative Therapy in Breast Cancer,
National Cancer Institute (USA)
2007, Community Service Award to the "Finding Your Way To Wellness" Committee,
Susan G. Komen Breast Cancer Foundation, Puget Sound Affiliate
2006, "Women of Valor" Award for Medicine and Health Care,
Helen H. Jackson
2005, C.J. Taylor Outstanding Community Volunteer Award,
Susan G. Komen Breast Cancer Foundation, Puget Sound Affiliate
2000, Outstanding Faculty Award,
University of Washington Continuing Medical Education Department
Previous Positions2002-2009, Associate Professor,
University of Washington,
School of Medicine,
Department of Medicine,
Division of Medical Oncology
1999-2006, Assistant Member,
Fred Hutchinson Cancer Research Center,
Clinical Research Division,
Breast
1998-2002, Director,
University of Washington,
School of Medicine,
Women's Cancer Genetics & Risk Reduction Clinic
1998-2002, Director,
University of Washington,
School of Medicine,
Cancer Center,
Patient & Physician Education & Outreach
1998-2002, Assistant Professor,
University of Washington,
School of Medicine,
Department of Medicine,
Division of Medical Oncology
1994-1997, Acting Instructor,
University of Washington,
School of Medicine,
Department of Medicine,
Division of Medical Oncology
Publications- Jotwani AC, Gralow JR (Dec 2009) Early detection of breast cancer: new biomarker tests on the horizon?, Molecular diagnosis & therapy, 13 (6), 349-57
 - Specht J, Gralow JR (Oct 2009) Neoadjuvant chemotherapy for locally advanced breast cancer., Seminars in radiation oncology, 19 (4), 222-8
 - Body JJ, Lipton A, Gralow J, Steger GG, Gao G, Yeh H, Fizazi K (Aug 2009) Effects of Denosumab in Patients with Bone Metastases, with and without Previous Bisphosphonate Exposure., Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
 - Sparano JA, Hortobagyi GN, Gralow JR, Perez EA, Comis RL (Jun 2009) Recommendations for research priorities in breast cancer by the Coalition of Cancer Cooperative Groups Scientific Leadership Council: systemic therapy and therapeutic individualization., Breast cancer research and treatment
 - Gralow JR, Biermann JS, Farooki A, Fornier MN, Gagel RF, Kumar RN, Shapiro CL, Shields A, Smith MR, Srinivas S, Van Poznak CH (Jun 2009) NCCN Task Force Report: Bone Health in Cancer Care., Journal of the National Comprehensive Cancer Network : JNCCN, 7 Suppl 3, S1-S32; quiz S33-S35
 - Muss HB, Berry DA, Cirrincione CT, Theodoulou M, Mauer AM, Kornblith AB, Partridge AH, Dressler LG, Cohen HJ, Becker HP, Kartcheske PA, Wheeler JD, Perez EA, Wolff AC, Gralow JR, Burstein HJ, Mahmood AA, Magrinat G, Parker BA, Hart RD, Grenier D, Norton L, Hudis CA, Winer EP (May 2009) Adjuvant chemotherapy in older women with early-stage breast cancer., The New England journal of medicine, 360 (20), 2055-65
 - Fizazi K, Lipton A, Mariette X, Body JJ, Rahim Y, Gralow JR, Gao G, Wu L, Sohn W, Jun S (Apr 2009) Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 (10), 1564-71
 - Winer E, Gralow J, Diller L, Karlan B, Loehrer P, Pierce L, Demetri G, Ganz P, Kramer B, Kris M, Markman M, Mayer R, Pfister D, Raghavan D, Ramsey S, Reaman G, Sandler H, Sawaya R, Schuchter L, Sweetenham J, Vahdat L, Schilsky RL (Feb 2009) Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 (5), 812-26
 - Chew HK, Barlow WE, Albain K, Lew D, Gown A, Hayes DF, Gralow J, Hortobagyi GN, Livingston R (Dec 2008) A phase II study of imatinib mesylate and capecitabine in metastatic breast cancer: Southwest Oncology Group Study 0338., Clinical breast cancer, 8 (6), 511-5
 - Schneider BP, Wang M, Radovich M, Sledge GW, Badve S, Thor A, Flockhart DA, Hancock B, Davidson N, Gralow J, Dickler M, Perez EA, Cobleigh M, Shenkier T, Edgerton S, Miller KD (Oct 2008) Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 (28), 4672-8
 - Dunnwald LK, Gralow JR, Ellis GK, Livingston RB, Linden HM, Specht JM, Doot RK, Lawton TJ, Barlow WE, Kurland BF, Schubert EK, Mankoff DA (Sep 2008) Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 (27), 4449-57
 - Bunnell C, Vahdat L, Schwartzberg L, Gralow J, Klimovsky J, Poulart V, Peck R, Thomas E (Jun 2008) Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancer., Clinical breast cancer, 8 (3), 234-41
 - Aapro M, Abrahamsson PA, Body JJ, Coleman RE, Colomer R, Costa L, Crinò L, Dirix L, Gnant M, Gralow J, Hadji P, Hortobagyi GN, Jonat W, Lipton A, Monnier A, Paterson AH, Rizzoli R, Saad F, Thürlimann B (Mar 2008) Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel., Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 19 (3), 420-32
 - Syrjala KL, Abrams JR, Polissar NL, Hansberry J, Robison J, DuPen S, Stillman M, Fredrickson M, Rivkin S, Feldman E, Gralow J, Rieke JW, Raish RJ, Lee DJ, Cleeland CS, DuPen A (Mar 2008) Patient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trial., Pain, 135 (1-2), 175-86
 - Perez EA, Suman VJ, Davidson NE, Sledge GW, Kaufman PA, Hudis CA, Martino S, Gralow JR, Dakhil SR, Ingle JN, Winer EP, Gelmon KA, Gersh BJ, Jaffe AS, Rodeheffer RJ (Mar 2008) Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 (8), 1231-8
 - Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, Gralow J (2008) Major depression after breast cancer: a review of epidemiology and treatment., General hospital psychiatry, 30 (2), 112-26
 - Lewis FM, Cochrane BB, Fletcher KA, Zahlis EH, Shands ME, Gralow JR, Wu SM, Schmitz K (Feb 2008) Helping Her Heal: a pilot study of an educational counseling intervention for spouses of women with breast cancer., Psycho-oncology, 17 (2), 131-7
 - Gralow JR, Zujewski JA, Winer E (Feb 2008) Preoperative therapy in invasive breast cancer: reviewing the state of the science and exploring new research directions., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 (5), 696-7
 - Gralow JR, Burstein HJ, Wood W, Hortobagyi GN, Gianni L, von Minckwitz G, Buzdar AU, Smith IE, Symmans WF, Singh B, Winer EP (Feb 2008) Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 (5), 814-9
 - Gralow J, Rugo H, Gradishar W, O'Shaughnessy JA, Jahanzeb M, Perez E, Tripathy D (Feb 2008) Novel taxane formulations in the treatment of breast cancer: a thought leader discussion and consensus roundtable., Clinical breast cancer, 8 (1), 33-7
 - Gralow J, Ozols RF, Bajorin DF, Cheson BD, Sandler HM, Winer EP, Bonner J, Demetri GD, Curran W, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Ramsey S, Reaman GH, Sawaya R, Schuchter LM, Sweetenham JW, Vahdat LT, Davidson NE, Schilsky RL, Lichter AS (Jan 2008) Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 (2), 313-25
 - Coleman RE, Body JJ, Gralow JR, Lipton A (2008) Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies., Cancer treatment reviews, 34 Suppl 1, S31-42
 - Miller K, Wang M, Gralow J, Dickler M, Cobleigh M, Perez EA, Shenkier T, Cella D, Davidson NE (Dec 2007) Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer., The New England journal of medicine, 357 (26), 2666-76
 - Specht JM, Tam SL, Kurland BF, Gralow JR, Livingston RB, Linden HM, Ellis GK, Schubert EK, Dunnwald LK, Mankoff DA (Sep 2007) Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP)., Breast cancer research and treatment, 105 (1), 87-94
 - Bowen DJ, Fann JR, Andersen MR, Rhew IC, Gralow JR, Lewis FM, Hunt JR, Palomares M, Moinpour CM, Ankerst DP (Sep 2007) Recruiting patients with breast cancer and their families to behavioral research in the post-HIPAA period., Oncology nursing forum, 34 (5), 1049-54
 - Gralow JR (Aug 2007) Bone density in breast cancer: when to intervene?, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 (22), 3194-7
 - Moore HC, Green SJ, Gralow JR, Bearman SI, Lew D, Barlow WE, Hudis C, Wolff AC, Ingle JN, Chew HK, Elias AD, Livingston RB, Martino S (May 2007) Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 (13), 1677-82
 - Gralow J, Tripathy D (Apr 2007) Managing metastatic bone pain: the role of bisphosphonates., Journal of pain and symptom management, 33 (4), 462-72
 - Ozols RF, Herbst RS, Colson YL, Gralow J, Bonner J, Curran WJ, Eisenberg BL, Ganz PA, Kramer BS, Kris MG, Markman M, Mayer RJ, Raghavan D, Reaman GH, Sawaya R, Schilsky RL, Schuchter LM, Sweetenham JW, Vahdat LT, Winn RJ (Jan 2007) Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 25 (1), 146-62
 - Linden HM, Stekhova SA, Link JM, Gralow JR, Livingston RB, Ellis GK, Petra PH, Peterson LM, Schubert EK, Dunnwald LK, Krohn KA, Mankoff DA (Jun 2006) Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24 (18), 2793-9
 - Gralow JR (2006) Breast cancer 2004: Progress and promise on the clinical front., Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB), 21 Suppl 1, 2
 - Hudis CA, Vogel CL, Gralow JR, Williams D (Jun 2005) Weekly epoetin alfa during adjuvant chemotherapy for breast cancer: effect on hemoglobin levels and quality of life., Clinical breast cancer, 6 (2), 132-42
 - Dunnwald LK, Gralow JR, Ellis GK, Livingston RB, Linden HM, Lawton TJ, Barlow WE, Schubert EK, Mankoff DA (Feb 2005) Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival., Cancer, 103 (4), 680-8
 - Gralow J (Feb 2005) Evolving role of bisphosphonates in women undergoing treatment for localized and advanced breast cancer., Clinical breast cancer, 5 Suppl (2), S54-62
 - Gralow J (Feb 2005) Evolving role of bisphosphonates in women undergoing treatment for localized and advanced breast cancer., Clinical breast cancer, 5 Suppl (2), S54-62
 - Winer EP, Hudis C, Burstein HJ, Wolff AC, Pritchard KI, Ingle JN, Chlebowski RT, Gelber R, Edge SB, Gralow J, Cobleigh MA, Mamounas EP, Goldstein LJ, Whelan TJ, Powles TJ, Bryant J, Perkins C, Perotti J, Braun S, Langer AS, Browman GP, Somerfield MR (Jan 2005) American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 (3), 619-29
 - Pierce LJ, Hutchins LF, Green SR, Lew DL, Gralow JR, Livingston RB, Osborne CK, Albain KS (Jan 2005) Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 (1), 24-9
 - Gralow JR (2005) Optimizing the treatment of metastatic breast cancer., Breast cancer research and treatment, 89 Suppl 1, S9-S15
 - Eubank WB, Mankoff D, Bhattacharya M, Gralow J, Linden H, Ellis G, Lindsley S, Austin-Seymour M, Livingston R (Aug 2004) Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast cancer., AJR. American journal of roentgenology, 183 (2), 479-86
 - Bellon JR, Livingston RB, Eubank WB, Gralow JR, Ellis GK, Dunnwald LK, Mankoff DA (Aug 2004) Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC)., American journal of clinical oncology, 27 (4), 407-10
 - Yaziji H, Goldstein LC, Barry TS, Werling R, Hwang H, Ellis GK, Gralow JR, Livingston RB, Gown AM (Apr 2004) HER-2 testing in breast cancer using parallel tissue-based methods., JAMA : the journal of the American Medical Association, 291 (16), 1972-7
 - Hillner BE, Ingle JN, Chlebowski RT, Gralow J, Yee GC, Janjan NA, Cauley JA, Blumenstein BA, Albain KS, Lipton A, Brown S (Nov 2003) American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 (21), 4042-57
 - Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Schubert EK, Tseng J, Lawton TJ, Linden HM, Livingston RB (Nov 2003) Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy., Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 44 (11), 1806-14
 - Winer EP, Hudis C, Burstein HJ, Bryant J, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gelber R, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP (Jul 2003) American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 21 (13), 2597-9
 - Bartelink H, Benz C, Cleveland D, Dorn R, Gralow J, Gradishar WJ, Grant K, Heimann R, Hellman S, Hudis C, Kerbel R, Lippman M, Lung J, Posner MC, Steeg P, Vestal R, Weichselbaum RR, Zetter B (Jul 2003) Expedition Inspiration Fund for Breast Cancer Research Meeting 2003., Breast cancer research and treatment, 80 (2), 139-44
 - Benz C, Clark G, Conzen S, Dorn R, Fuqua S, Gralow J, Greene G, Heimann R, Hellman S, Lippman M, Rosen N, Weiner L (Mar 2003) Consensus statement: Expedition Inspiration fund for breast cancer research meeting 2002., Breast cancer research and treatment, 78 (1), 127-31
 - Garrison JA, McCune JS, Livingston RB, Linden HM, Gralow JR, Ellis GK, West HL, Myalgias and arthralgias associated with paclitaxel, Oncology (williston Park, N.y.), 17(2), 271-7; discussion 28, February 2003
 - Gralow JR, Bisphosphonates as adjuvant treatment for breast cancer, Bmj (clinical Research Ed.), 325(7372), 1051-2, November 2002
 - Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Schubert EK, Charlop AW, Tseng J, Rinn KJ, Livingston RB, [Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer
are correlated with tumor blood flow, Nuclear Medicine and Biology, 29(7), 719-27, October 2002
 - Ellis GK, Livingston RB, Gralow JR, Green SJ, Thompson T, Dose-dense anthracycline-based chemotherapy for node-positive breast
cancer, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 20(17), 3637-43, September 2002
 - Stafford SE, Gralow JR, Schubert EK, Rinn KJ, Dunnwald LK, Livingston RB, Mankoff DA, Use of serial FDG PET to measure the response of bone-dominant breast
cancer to therapy, Academic Radiology, 9(8), 913-21, Aug 2002
 - Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP, American Society of Clinical Oncology technology assessment on the use of
aromatase inhibitors as adjuvant therapy for women with hormone
receptor-positive breast cancer: status report 200, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 20(15), 3317-27, Aug 2002
 - Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Charlop A, Lawton TJ, Schubert EK, Tseng J, Livingston RB, Blood flow and metabolism in locally advanced breast cancer: relationship
to response to therapy, Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine., 43(4), 500-9, April 2002
 - Eubank WB, Mankoff DA, Vesselle HJ, Eary JF, Schubert EK, Dunnwald LK, Lindsley SK, Gralow JR, Austin-Seymour MM, Ellis GK, Livingston RB, Detection of locoregional and distant recurrences in breast cancer
patients by using FDG PET, Radiographics : a Review Publication of the Radiological Society of North America, Inc., 22(1), 5-17, 2002
 - Gralow JR, The role of bisphosphonates as adjuvant therapy for breast cancer, Current Oncology Reports, 3(6), 506-15, November 2001
 - Wilkie DJ, Huang HY, Berry DL, Schwartz A, Lin YC, Ko NY, Chen A, Gralow J, Lindsley SK, Fitzgibbon D, Cancer symptom control: feasibility of a tailored, interactive
computerized program for patients, Family and Community Health, 24(3), 48-62, October 2001
 - Gralow JR, Livingston RB, University of Washington high-dose cyclophosphamide, mitoxantrone, and
etoposide experience in metastatic breast cancer: unexpected cardiac
toxicity, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 19(18), 3903-4, September 2001
 - Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL, Relation of body mass index to tumor markers and survival among young
women with invasive ductal breast carcinoma, Cancer, 92(4), 720-9, August 2001
 - Eubank WB, Mankoff DA, Takasugi J, Vesselle H, Eary JF, Shanley TJ, Gralow JR, Charlop A, Ellis GK, Lindsley KL, Austin-Seymour MM, Funkhouser CP, Livingston RB, 18fluorodeoxyglucose positron emission tomography to detect mediastinal or
internal mammary metastases in breast cancer, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 19(15), 3516-23, August 2001
 - Mankoff DA, Peterson LM, Tewson TJ, Link JM, Gralow JR, Graham MM, Krohn KA, [18F]fluoroestradiol radiation dosimetry in human PET studies, Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine., 42(4), 679-84, April 2001
 - Bellon JR, Lindsley KL, Ellis GK, Gralow JR, Livingston RB, Austin Seymour MM, Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in
high-risk breast cancer, International Journal of Radiation Oncology, Biology, Physics, 48(2), 393-7, September 2000
 - Bernhard H, Huseby ES, Hand SL, Lohmann M, Batten WY, Disis ML, Gralow JR, Meyer zum Buschenfelde KH, Ohlen C, Cheever MA, Dendritic cells lose ability to present protein antigen after stimulating
antigen-specific T cell responses, despite upregulation of MHC class II
expression, Immunobiology, 201(5), 568-82, April 2000
 - Bowen D, McTiernan A, Burke W, Powers D, Pruski J, Durfy S, Gralow J, Malone K, Participation in breast cancer risk counseling among women with a family
history, Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 8(7), 581-5, July 1999
 - Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Drucker MJ, Livingston RB, Monitoring the response of patients with locally advanced breast carcinoma
to neoadjuvant chemotherapy using [technetium 99m]-sestamibi
scintimammography, Cancer, 85(11), 2410-23, June 1999
 - Ellis GK, Gralow JR, Pierce HI, Williams MA, Livingston RB, Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast cancer: high complete response rate in a phase I-II study of doxorubicin-treated patients., Journal of Clinical Oncology, 17(5), 1407-12, May 1999
 - Hathaway PB, Mankoff DA, Maravilla KR, Austin-Seymour MM, Ellis GK, Gralow JR, Cortese AA, Hayes CE, Moe RE, Value of combined FDG PET and MR imaging in the evaluation of suspected
recurrent local-regional breast cancer: preliminary
experience, Radiology, 210(3), 807-14, March 1999
 - McTiernan A, Ulrich C, Kumai C, Bean D, Schwartz R, Mahloch J, Hastings R, Gralow J, Potter JD, Anthropometric and hormone effects of an eight-week exercise-diet
intervention in breast cancer patients: results of a pilot
study, Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 7(6), 477-81, June 1998
 - Tait DL, Jensen RA, Holt JT, Johnson DH, Gralow J, King MC (Apr 1998) Gene therapy for breast and ovarian cancer with BRCA1., Breast disease, 10 (1-2), 89-98
 - Disis ML, Pupa SM, Gralow JR, Dittadi R, Menard S, Cheever MA, High-titer HER-2/neu protein-specific antibody can be detected in patients
with early-stage breast cancer, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 15(11), 3363-7, November 1997
 - Anderson BO, Austin-Seymour MM, Gralow JR, Moe RE, Byrd DR (Nov 1997) A Multidisciplinary Approach to Locoregional Management of the Axilla for Primary Operable Breast Cancer., Cancer control : journal of the Moffitt Cancer Center, 4 (6), 491-499
 - Clark JI, Alpaugh RK, von Mehren M, Schultz J, Gralow JR, Cheever MA, Ring DB, Weiner LM, Induction of multiple anti-c-erbB-2 specificities accompanies a classical
idiotypic cascade following 2B1 bispecific monoclonal antibody
treatment, Cancer Immunology, Immunotherapy : Cii, 44(5), 265-72, July 1997
 - Livingston RB, Ellis GK, Gralow JR, Williams MA, White R, McGuirt C, Adamkiewicz BB, Long CA, Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer., Journal of Clinical Oncology, 15(4), 1395-400, 1997
 - Disis ML, Bernhard H, Shiota FM, Hand SL, Gralow JR, Huseby ES, Gillis S, Cheever MA, Granulocyte-macrophage colony-stimulating factor: an effective adjuvant
for protein and peptide-based vaccines, Blood, 88(1), 202-10, July 1996
 - Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahashi M, Chen W, Immunity to oncogenic proteins, Immunological Reviews, 145, 33-59, June 1995
 - Bernhard H, Disis ML, Heimfeld S, Hand S, Gralow JR, Cheever MA, Generation of immunostimulatory dendritic cells from human CD34+
hematopoietic progenitor cells of the bone marrow and peripheral
blood, Cancer Research, 55(5), 1099-104, March 1995
 - Disis ML, Bernhard H, Gralow JR, Hand SL, Emery SR, Calenoff E, Cheever MA, Immunity to the HER-2/neu oncogenic protein, Ciba Foundation Symposium, 187, 198-207; discussion, 1994
 - Miller RA, Lowder JN, Gralow J, Meeker T, Levy R, In vitro tests that predict tumor-associated idiotype levels in the serum
of patients with B cell lymphomas and leukemias, Blood, 69(4), 1249-54, April 1987
 - Lowder JN, Meeker TC, Campbell M, Garcia CF, Gralow J, Miller RA, Warnke R, Levy R, Studies on B lymphoid tumors treated with monoclonal anti-idiotype
antibodies: correlation with clinical responses, Blood, 69(1), 199-210, January 1987
 - Dubeau L, Chandler LA, Gralow JR, Nichols PW, Jones PA, Southern blot analysis of DNA extracted from formalin-fixed pathology
specimens, Cancer Research, 46(6), 2964-9, June 1986
 - Thompson JM, Gralow JR, Levy R, Miller RA, The optimal application of forward and ninety-degree light scatter in flow
cytometry for the gating of mononuclear cells, Cytometry : the Journal of the Society for Analytical Cytology, 6(5), 401-6, September 1985
 - Miller RA, Gralow J, The induction of Leu-1 antigen expression in human malignant and normal B
cells by phorbol myristic acetate (PMA), Journal of Immunology (baltimore, Md. : 1950), 133(6), 3408-14, December 1984
 - Sklar J, Cleary ML, Thielemans K, Gralow J, Warnke R, Levy R, Biclonal B-cell lymphoma, The New England Journal of Medicine, 311(1), 20-7, July 1984
 - Thielemans K, Maloney DG, Meeker T, Fujimoto J, Doss C, Warnke RA, Bindl J, Gralow J, Miller RA, Levy R, Strategies for production of monoclonal anti-idiotype antibodies against
human B cell lymphomas, Journal of Immunology (baltimore, Md. : 1950), 133(1), 495-501, July 1984
 - Anderson BO, Braun S, Carlson RW, Gralow JR, Lagios MD, Lehman C, Schwartsmann G, Vargas HI, Overview of breast health care guidelines for countries with limited resources., The breast journal, 9 Suppl 2, S42-50

Profile DetailsIndividual Expertise profile of Julie R. Gralow, Copyright Julie R. Gralow. © COS Expertise TM, 2010, ProQuest LLC All rights reserved. |